PARP1 and prostate carcinoma: These data are in line with earlier published data showing a CD mediated increase in cleaved caspase-3 (active form) and PARP cleavage in glioblastoma cells [38], in prostate cancer cells [37], in triple negative breast cancer cells [36], and in colon adenocarcinoma cells [39].